6 products found
CIS Pharma AG Products
-
CIS Pharma - Novel Antibody Drug Conjugates (ADCs)
CIS Pharma develops novel antibody-drug- conjugates (ADCs) based on our proprietary polymer carrier platform. Our polymers serve as carriers that are loaded with cytotoxic drugs, radioisotopes or other active entities. The carrier together with its cargo is conjugated to a target-specific antibody using site-directed linker chemistry, different from the linker chemistry used to attach the payload. As a result, our polymer drug conjugates (PDC) offer a ...
-
CIS Pharma - Bioinspired Contact Lens Care Technology
CIS Pharma has developed the new standard of bio-inspired contact lens care solutions for cleaning, disinfection and storage of silicone hydrogel contact lenses. Compared to market leaders, the product shows superior disinfecting power. In addition, the product offers an innovative comfort-agent complex that delivers an unsurpassed amount of hyaluronic acid to the contact lens surface. The complex includes a physiological mix of minerals for protection ...
-
CIS Pharma - Bio-inspired Polymer
Werner Schäfer, the founder of CIS Pharma, envisioned the synthesis of a bio-inspired polymer for tissue regeneration and site-specific drug delivery. We have generated a platform of proprietary polymers together with a toolkit to create biomaterials specific to their application and site of use. We are continuously expanding the platform technology to create new applications in the field of ...
-
CIS Pharma - Cefuroxime Application System
The Cefuroxime Application System is CIS Pharma’s patented drug/device combination for preparation and injection of cefuroxime intracameral antibiotic to prevent Endophthalmitis. It meets the cataract surgeon’s need to dilute and inject 1mg cefuroxime in a safe, precise and standardized ...
-
CIS Pharma - Connected Eye Drop Dispenser
CIS Pharma offers a platform of different eye drop dispenser technologies designed for preservative-free drug formulations as eye-drops or as a spray. Devices to control eye-lids as well as digital technology to monitor drug dispense are available to improve the compliance of patients. The platform is a result of our expertise in ophthalmology: since the early eighties CIS Pharma has developed and licensed a number of drug substances for and to market ...
-
CIS Pharma - Polymer-based Delivery System
RNA interference (RNAi) is a mechanism used to defend against external invasion. Oligo- and poly-nucleotide based RNAi therapeutics comprise a high clinical potential for unmet medical diseases and are seen as promising approach to combat a number of different indications including oncology, genetic disorders, auto-immune disorders, orphan diseases and viral ...